Clinical Trial Update: Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating the safety and efficacy of JTT-705 in combination with simvastatin 40 mg in patients with low HDL levels. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• JTT-705
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED